Suchergebnisse - (Subject:"angiotensin-converting enzyme inhibitors")

PubPharm (48)

1

Sacubitril/valsartan versus enalapril on exercise capacity in patients with heart failure with reduced ejection fraction : A randomized, double-blind, active-controlled study

enthalten in: American heart journal | 2021

von Dos Santos, M. | Alves, M. | Jordão, C. | +9

2

Design for the sacubitril/valsartan (LCZ696) compared with enalapril study of pediatric patients with heart failure due to systemic left ventricle systolic dysfunction (PANORAMA-HF study)

enthalten in: American heart journal | 2017

von Shaddy, R. | Canter, C. | Halnon, N. | +8

3

The effects of sacubitril/valsartan on coronary outcomes in PARADIGM-HF

enthalten in: American heart journal | 2017

von Mogensen, U. | Køber, L. | Kristensen, S. | +12

4

Lessons learned from a pediatric clinical trial : the Pediatric Heart Network angiotensin-converting enzyme inhibition in mitral regurgitation study

enthalten in: American heart journal | 2011

von Li, J. | Colan, S. | Sleeper, L. | +10

5

Rationale and design of a trial of angiotensin-converting enzyme inhibition in infants with single ventricle

enthalten in: American heart journal | 2009

von Hsu, D. | Mital, S. | Ravishankar, C. | +89

6

Long-term treatment with sulfhydryl angiotensin-converting enzyme inhibition reduces carotid intima-media thickening and improves the nitric oxide/oxidative stress pathways in newly diagnosed patients with mild to moderate primary hypertension

enthalten in: American heart journal | 2008

von Napoli, C. | Bruzzese, G. | Ignarro, L. | +9

7

A randomized trial of carvedilol after renin-angiotensin system inhibition in chronic Chagas cardiomyopathy

enthalten in: American heart journal | 2007

von Botoni, F. | Poole-Wilson, P. | Ribeiro, A. | +10

CommentIn: Am Heart J. 2007 Nov;154(5):e35; author reply e33. - PMID 17967576

8

Antihypertensive therapy and regression of coronary artery disease : insights from the Comparison of Amlodipine versus Enalapril to Limit Occurrences of Thrombosis (CAMELOT) and Norvasc for Regression of Manifest Atherosclerotic Lesions by Intravascular Sonographic Evaluation (NORMALISE) trials

enthalten in: American heart journal | 2006

von Brener, S. | Ivanc, T. | Poliszczuk, R. | +5

9

Quantification of the risk and predictors of hyperkalemia in patients with left ventricular dysfunction : a retrospective analysis of the Studies of Left Ventricular Dysfunction (SOLVD) trials

enthalten in: American heart journal | 2006

von de Denus, S. | Tardif, J. | White, M. | +4

10

Enalapril suppresses ventricular remodeling more effectively than losartan in patients with acute myocardial infarction

enthalten in: American heart journal | 2005

von Onodera, H. | Matsunaga, T. | Tamura, Y. | +9

CommentIn: Evid Based Cardiovasc Med. 2006 Mar;10(1):32-4. - PMID 16530673

1
2
3
4
5
Nächster »
[5]